Clinical Data Posts 64 Percent Rise in Fiscal Q2 Revenue as Icoria Ag Line Winds Down and Erases Profits

Nov 15, 2006

NEW YORK (GenomeWeb News) — Clinical Data today said fiscal second-quarter 2007 revenues increased 64 percent as R&D spending on vilazodone studies rose 54 percent and profit turned swung to a loss.

Total receipts for the three months ended Sept. 30 increased to $19.2 million from $11.7 million year over year.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Privacy Policy Information, Please

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

Moving the Parts About

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

This Week in Science

In Science this week: genetic overlap among many psychiatric disorders, and more.

Just Skip that Step

The Economist writes that an increasing number of scientific journals don't do peer review.

Main menu